FDA 510(k)

CYBREX PHENOBARBITAL

K-Number: K801566 · 1980-07-21

Decision Date1980-07-21

Product Code

DecisionSubstantially Equivalent

Device Summary

CYBREX PHENOBARBITAL is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Laboratories. It received FDA 510(k) clearance on 1980-07-21 under 510(k) number K801566. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CYBREX PHENOBARBITAL?

CYBREX PHENOBARBITAL is a medical device that received FDA 510(k) clearance on 1980-07-21. The listed applicant is Abbott Laboratories. The 510(k) number is K801566.

When did CYBREX PHENOBARBITAL receive FDA 510(k) clearance?

CYBREX PHENOBARBITAL received FDA 510(k) clearance on 1980-07-21, under 510(k) number K801566.

Who is the listed applicant for CYBREX PHENOBARBITAL?

The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Abbott Laboratories as applicant

K262156Anti-HCV Next K252424Anti-HCV Next K243500ARCHITECT iGentamicin K243168Alinity i Rubella IgG K243283Alinity h-series System K233932Alinity i Toxo IgM

View all 876 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.